The South Korean technology giant’s stock repurchase plan comes amid investor concerns over its flagship memory-chip business, which is missing out on the artificial intelligence boom.
Related Posts
Sanofi in Talks to Sell Controlling Stake in Consumer Health Arm to CD&R
The French drugmaker said the negotiations are for a potential sale of a 50% controlling stake in Opella.
CVC Confident After Key Metric Beat
CVC Capital Partners reported better-than-expected management fee earnings for the first half of the year and said it was confident on its outlook.
Former Healthcare CEO Is Convicted of Plan to Conceal Insider Trading
Ex-Ontrak chairman was accused of abusing trading strategy that usually shields executives against suspicions of insider trading.